{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04612",
    "Peptide Name": "ARin-s (Arenicin-1 analog, Arg-rich, synthetic AMPs, 1S=S, UCSS1a)",
    "Source": "local amino acid shuffling, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RWCRRYRVRVRGVLVYAYVCW",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 2.61,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "52%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (65.22%) toArenicin-1R: 29%, V: 24%, Y: 14%, C=W: 10%.Activity: active against Gram- E.coli ML35p or ATCC 25922 or M15 (MIC 4-8 uM), P. aeruginosa ATCC 27853 or clinical c.i. (MIC 4->16 uM), A. baumanii c.i.  (MIC 16 uM), Gram+ L. monocytogenes EGD (MIC 2 uM), S. aureus 710A or ATCC 25923 or MRSA ATCC 33591 or clinical c.i. (MIC 16->16 uM), S-intermidius (MIC >16 uM). This symmetry related changes made the peptide less potent.",
    "Author": "Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.2019",
    "Reference": "Mar Drugs. 2019 Jun 23;17(6):376. doi: 10.3390/md17060376.PubMed",
    "Title": "Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization."
  },
  "3D Structure": []
}